Pornel B - Search Results - PubMed

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Pornel B - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

21 results

Page of 3

Results are displayed in a computed author sort order. The Results By Year timeline is not available.

Page 1

1

Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.

Quereux C, Pornel B, Bergeron C, Ferenczy A. Quereux C, et al. Among authors: pornel b. Maturitas. 2006 Feb 20;53(3):299-305. doi: 10.1016/j.maturitas.2005.05.015. Epub 2005 Jul 25. Maturitas. 2006. PMID: 16043317

2

Endometrial safety assessment of a specific and standardized soy extract according to international guidelines.

Palacios S, Pornel B, Bergeron C, Chantre P, Nogales F, Aubert L, Vazquez F, Eden J, Mares P. Palacios S, et al. Among authors: pornel b. Menopause. 2007 Nov-Dec;14(6):1006-11. doi: 10.1097/gme.0b013e3180590c42. Menopause. 2007. PMID: 17603393 Clinical Trial.

3

Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.

Rozenbaum H, Birkhäuser M, De Nooyer C, Lambotte R, Pornel B, Schneider H, Studd J. Rozenbaum H, et al. Among authors: pornel b. Maturitas. 1996 Nov;25(3):161-73. doi: 10.1016/s0378-5122(96)01068-7. Maturitas. 1996. PMID: 8981333 Clinical Trial.

4

Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerability.

Rozenbaum H, Birkhäuser M, De Nooyer C, Lambotte R, Pornel B, Schneider H, Studd J, Thebault J. Rozenbaum H, et al. Among authors: pornel b. Maturitas. 1996 Nov;25(3):175-85. doi: 10.1016/s0378-5122(96)01074-2. Maturitas. 1996. PMID: 8981334 Clinical Trial.

5

Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route.

Delmas PD, Marianowski L, Perez Ade C, Ribot C, Pornel B, Palacios S, Lopes P; Aerodiol Study Group. Delmas PD, et al. Among authors: pornel b. Maturitas. 2004 Jun 15;48(2):85-96. doi: 10.1016/j.maturitas.2004.01.012. Maturitas. 2004. PMID: 15172082 Clinical Trial.

6

Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.

Rozenberg S, Pornel B, Koninckx PR, Palacios S, Christiansen C. Rozenberg S, et al. Among authors: pornel b. Hum Reprod. 2009 Jul;24(7):1739-47. doi: 10.1093/humrep/dep067. Epub 2009 Apr 7. Hum Reprod. 2009. PMID: 19351658 Clinical Trial.

7

Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.

Pornel B, Genazzani AR, Costes D, Dain MP, Lelann L, Vandepol C. Pornel B, et al. Maturitas. 1995 Nov;22(3):207-18. doi: 10.1016/0378-5122(95)00938-h. Maturitas. 1995. PMID: 8746878 Clinical Trial.

8

Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.

Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA; TOTAL Study Investigators Group. Hammar ML, et al. Among authors: pornel b. BJOG. 2007 Dec;114(12):1522-9. doi: 10.1111/j.1471-0528.2007.01537.x. BJOG. 2007. PMID: 17995496 Clinical Trial.

9

Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.

al-Azzawi F, Wahab M, Thompson J, Pornel B, Hirvonen E, Ylikorkala O, van der Mooren MJ, Dillon J, Magaril C. al-Azzawi F, et al. Among authors: pornel b. Climacteric. 2001 Dec;4(4):343-54. Climacteric. 2001. PMID: 11770191 Clinical Trial.

10

Oral 17beta-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women.

Pornel B, Chevallier O, Netelenbos JC. Pornel B, et al. Menopause. 2002 May-Jun;9(3):171-8. doi: 10.1097/00042192-200205000-00005. Menopause. 2002. PMID: 11973440 Clinical Trial.

21 results

Page of 3